Inventor · disambiguated record
Brian Wilson
Also filed as: WILSON BRIAN · WILSON BRIAN JOHN
8 granted patents·4 pending applications·35 citations·filing 2004–2022
80Inventor score
Files withONTARIO INSTITUTE FOR CANCER RES OICR5PROPELLON THERAPEUTICS INC4ADJABENG GEORGE1KUNTZ KEVIN1SMITHKLINE BEECHAM CORP1
Top patents by PatentIndex Score
12 records- 0190US8415345B2Benzene sulfonamide thiazole and oxazole compoundsADJABENG GEORGE·Filed 2009·Granted Apr 9, 2013·26 cites·14 claims
- 0280US11518764B2Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interactionONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2019·Granted Dec 6, 2022·3 cites·18 claims
- 0379US11174250B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·3 cites·23 claims
- 0470US8093239B2Imidazopyridine kinase inhibitorsKUNTZ KEVIN·Filed 2008·Granted Jan 10, 2012·2 cites·37 claims
- 0568US11319299B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 0661US12264147B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·2 claims
- 0756US2024343704A1Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 0855US2024425479A1Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 0954US2024317723A1Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1046US7462614B2Imidazotriazine compoundsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Dec 9, 2008·0 cites·27 claims
- 1145US2020385371A1Inhibitors of wdr5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1242US11242351B2Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Feb 8, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Brian Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →